COMy 2025 Scientific Program course
All those who wish to attend the COMy Congress online can do so here and complete the full CME-accredited program course.
COMy 2025 Scientific Program course Read More »
Resident/Trainee
Management of chronic myeloid leukemia (CML) in special populations
Mhairi Copland Mhairi Copland PhD, Professor of Translational Haematology and Honorary Consultant in Haematology at the University of Glasgow
Management of chronic myeloid leukemia (CML) in special populations Read More »
Management of AL amyloidosis : an update
Hasib Sidiqi Prof Hasib Sidiqi MBBS, FRACP, FRCPA, Consultant Haematologist, Adjunct Associate Professor, Curtin Medical School
Management of AL amyloidosis : an update Read More »
The Emerging Role of the Immune Microenvironment in Hematological Malignancies
Katia Beider Katia Beider PhD, Division of Hematology and BMT, Chaim Sheba Medical Center Tel Aviv University, Tel-Hashomer, Israel
The Emerging Role of the Immune Microenvironment in Hematological Malignancies Read More »
TMA and stem cell transplantation (SCT)
Sumithira Vasu Dr. Sumithira Vasu, MD is a hematologist in Columbus, OH. She is affiliated with Ohio State University Hospital.
TMA and stem cell transplantation (SCT) Read More »
Sickle cell disease landscape and challenges
Mariane de Montalembert Mariane de Montalembert PhD, head of the Hemoglobin Diseases Unit at the Necker University Hospital.
Sickle cell disease landscape and challenges Read More »
State of the Art Management of Follicular Lymphoma
Nilanjan Ghosh Nilanjan Ghosh, MD, PhD, oncologist in Charlotte, North Carolina and is affiliated with Atrium Health Carolinas Medical Center.
State of the Art Management of Follicular Lymphoma Read More »
Allogeneic Stem Cell Transplantation for Myelofibrosis
Ibrahim Yakoub-Agha Prof. Ibrahim Yakoub, professor for the Department of Hematology at Lille Faculty of Medicine. Editor in Chief of Current Research in Translational Medicine.
Allogeneic Stem Cell Transplantation for Myelofibrosis Read More »
Maintenance therapy after allogeneic stem cell transplantation for FLT3-ITD AML: current status and guidelines
Ali Bazarbachi Ali Bazarbachi MD, PhD is a Professor of Medicine (Hematology and Oncology), Anatomy, Cell Biology and Physiological Sciences. Founding Director of the bone marrow transplantation program at the American University of Beirut Medical Center.